Tom van Blarcom
Direttore Tecnico/Scientifico/R&S presso KYVERNA THERAPEUTICS, INC.
Profilo
Tom van Blarcom is currently the Senior Vice President & Head-Research at Kyverna Therapeutics, Inc. He previously worked as the Senior Director-Medical at Genentech, Inc., the Executive Director & Head-Protein Engineering at Allogene Therapeutics, Inc., and the Vice President at Horizon Therapeutics, Inc. Dr. van Blarcom completed his undergraduate studies at Universite Paris Est.
Creteil Val De Marne and North Carolina State University.
He holds a doctorate degree from the University of Texas at Austin.
Posizioni attive di Tom van Blarcom
Società | Posizione | Inizio |
---|---|---|
KYVERNA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Tom van Blarcom
Società | Posizione | Fine |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | - |
ALLOGENE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Corporate Officer/Principal | - |
Formazione di Tom van Blarcom
Universite Paris Est Creteil Val De Marne | Undergraduate Degree |
University of Texas at Austin | Doctorate Degree |
North Carolina State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
KYVERNA THERAPEUTICS, INC. | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Horizon Therapeutics, Inc.
Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Tom van Blarcom